JAK2 and acquired polycythemia vera: However, we noticed the Chinese PV patients have a relatively low mutation frequency in the JAK2 V617F mutation (82%), while the mutations in JAK2 exon 12 were much more pervasive (13%) than in the Westerns [[25],[26]], and other East Asians [[27],[28]].